About Us
2025 OKATOD Conference - The Evolving Field of Opioid Treatment
Friday, October 17 | 8:00 am to 4:30 pm | Metro Technology Centers, 1900 Springlake Dr, Oklahoma City, OK 73111
Our History
The Oklahoma Association for the Treatment of Opioid Dependence (OKATOD) was founded in 2010 to enhance the quality of patient care in treatment programs by promoting the growth and development of comprehensive opioid treatment services throughout Oklahoma.
OKATOD hosts an annual conference, bringing together treatment professionals, policymakers, advocates, and researchers dedicated to advancing care for individuals with opioid use disorder. Our conference features dynamic plenary sessions, engaging workshops, and inspiring keynote presentations that highlight the latest innovations, policy updates, and clinical practices shaping the future of treatment.
We encourage you to join us as we foster collaboration, share knowledge, and strengthen the recovery community across Oklahoma and beyond. We are committed to bringing the most relevant and impactful discussions to Oklahoma’s treatment and recovery professionals.

Our Mission
Bringing together and igniting governmental, private, and non-profit partners to develop, assist, and disseminate various solutions that aim to reduce opioid abuse and enhancing outcomes for those affected by the opioid crisis, including individuals, families, and communities.
Meet Our Team
- Chief Clinical Officer, Maric Healthcare
Dr. Mark Stavros, MD, FACEP, FASAM
Chief Medical Officer, Maric HealthcareLarry Lovelace, DO, FACEP, FARP
Medical Director, Maric Healthcare
Meet Our Conference Speakers

David Magee
Presenting "America Has a Substance & Mental Health Problem: How to Fix It"
Learn more about Mr. MageeDavid Magee is an inspirational speaker on student, family and community well-being, a podcast host, and the bestselling author of the award-winning book “Dear William: A Father’s Memoir of Addiction, Recovery, Love and Loss.” Featured on CBS Mornings, Dear William is a Publisher’s Weekly national bestseller, a Best Book of the South 2021 (Reckon), and receiving a Starred Review from Kirkus. It’s in development for film by director Andrew Hyatt (The Blind; Sight).
David is a sought-after speaker in communities, companies, schools, universities nationwide, inspirationally addressing mental health resiliency and recovery, and finding lasting joy and purpose. His message about what is often a difficult topic is well-received by audiences because it is relatable, inspirational and applicable.
He’s a creator of the William Magee Institute for Student Wellbeing at the University of Mississippi. The Magee Institute is named after David’s late son, William, who died of an accidental drug overdose.
In addition to the Magee Institute, David helped inspire and create the William Magee Center for Wellness Education at the University of Mississippi, which focuses on helping students on campus with alcohol and other drug education and support.
David is also founder and CEO of The Magee Foundation, which works in opioid abatement and mental health healing for students and families. Through storytelling and education, he leads initiatives that help students, families, and communities flourish.
David has been a daily newspaper publisher, a media company president, an award-winning columnist for newspapers and Newsweek, a small business owner, a regular guest on CNBC, and once hosted a national cable TV and radio program, The David Magee Show.
He is the author of a dozen books, including How Toyota Became #1 (Penguin), named a Top 10 Business Book of the Year from the American Library Association, and The Education of Mr. Mayfield, a Best Book of the South (2009). Other books include The John Deere Way (Wiley) and Playing to Win: Jerry Jones and the Dallas Cowboys (Random).
You can even find David featured prominently on multiple History Channel episodes, including explaining America’s history with inventing charcoal and the outdoor barbecue as we know it today and the surprising history of rental cars and the country’s role in that.

Kenneth Stoller, MD, DLFAPA
Presenting "Recent Movement in the OTP Field: Reducing Restrictions, Stressing Patient Centeredness, and Emphasizing Harm Reduction"
Learn more about Dr. StollerKenneth Stoller is the Director of Johns Hopkins Broadway Center for Addiction and a Professor of Clinical Psychiatry and Behavioral Sciences at Johns Hopkins University School of Medicine. He is also the Medical Director of Behavioral Health for Johns Hopkins Health Plans. His area of expertise is treatment of substance use problems and the use of methadone and buprenorphine. His research interests have centered on cost issues as they relate to drug abuse and treatment, methods to enhance treatment adherence and retention, and co-occurring psychiatric, medical, pain, and substance use disorders (SUDs). His published manuscripts and book chapters focus on the use of adaptive stepped care, treatment incentives, and integrated treatment of co-occurring disorders in a single setting. He has a related focus on fostering policies and initiatives applied to health plans to improve health outcomes and value, such as improving detection of SUD and coordinating treatment of physical health, mental health, and SUDs. Accelerated by his service on the board of AATOD and its Maryland state chapter, he refocused his work on increasing access to, and quality of, medication-assisted therapies in Baltimore, the region, and nationally. This work has received increasing attention, especially as it relates to coordinated care using opioid treatment programs as hubs of expertise that coordinate with community physicians prescribing buprenorphine. Dr. Stoller created and implemented the first known buprenorphine hub and spoke collaborative care model in the nation, and this is the subject of numerous presentations, webinars, and white papers.
Dr. Stoller will speak about the recent movement by the field and oversight bodies toward reducing restrictions, stressing patient centeredness, and emphasizing harm reduction. He will discuss the role that OTPs specifically can play in their treatment and advocacy, in order to promote an approach that is maximally effective, high in quality, easily accessible, and aimed at rebuilding lives and communities.

Katie Harrison, MA
Presenting "Current MOUD Initiatives in Oklahoma"
Learn more about Ms. HarrisonKatie Harrison serves as the Division Director of Addiction Services for the Oklahoma Department of Mental Health and Substance Abuse Services, where she also holds the designation of State Opioid Treatment Authority. With decades of experience in mental health and substance use treatment services, Katie brings a deep understanding of both direct care and systems-level leadership.
She began her career providing direct services to individuals with serious mental illness and co-occurring disorders, later transitioning into state-level roles where she has contributed to policy development, program oversight, and initiatives designed to strengthen Oklahoma’s addiction service system.
In her current role, Katie works closely with treatment providers across Oklahoma to improve access, reduce stigma, and eliminate barriers to care. She believes deeply in cross-system collaboration and is committed to building a responsive, compassionate system that meets the needs of individuals and families impacted by substance use disorder.
Her leadership is grounded in both a personal connection to the work and an unwavering belief in the capacity for recovery and change.
Ms. Harrison will present current initiatives in Oklahoma related to MOUD. She will speak about the OTP prison pilot, ODMHSAS’s ongoing work with jails, and other initiatives. She will also share updates on trends in Oklahoma and current revisions to state statutes as well as talk about her plan as SOTA to visit OTP providers to offer support services.

Mark Stavros, MD, FACEP, FASAM
Presenting "Best Practices in the Evolving World of OTP"
Learn more about Dr. StavrosDr. Stavros serves as the Chief Medical Officer for Maric Healthcare, which operates opioid treatment programs across seven states, including seven OTPs in Oklahoma. He also serves as the Medical Director for the Western Territory of CMS and as a member of CMS’s Medical Advisory Board along with Dr. Sherrick and Dr. Tamar. He is board certified in both emergency medicine and addiction medicine. Dr. Stavros was awarded the Air Force Health Professions Scholarship and received his medical degree at Creighton University. He completed his residency in emergency medicine at St. Vincent’s Emergency Medicine Residency Program in Ohio. He has worked as an emergency physician in the panhandle of Florida for the past 26 years and served as the Emergency Department Medical Director for West Florida Hospital and its associated free-standing emergency departments for the past 9 years. Dr. Stavros is an Associate Clinical Professor at Florida State University College of Medicine. He serves as both Education and Clerkship Director of Emergency Medicine for Florida State University.
Dr. Stavros will present Best Practices in the Evolving World of OTP.

Larry Lovelace, DO, FACEP, FARP
Presenting "Locked Up, But Not Locked Out: Expanding Methadone Access in the Oklahoma Prison System"
Learn more about Dr. LovelaceWith 25 years of experience as an emergency room trauma physician, Dr. Lovelace has experience on both sides of the opioid epidemic. Dr. Lovelace previously served as a Medical Director at a local methadone clinic, majored in psychology at the University of Oklahoma, received his medical degree from Oklahoma State University, and interned at Ft. Bragg at Womack Army Community Hospital. Dr. Lovelace is board certified by the American Board of Emergency Medicine.
Dr. Lovelace’s presentation explores the implementation of methadone treatment for opioid use disorder within the prison system. It highlights the clinical benefits, including reduced overdose risk, improved post-release outcomes, and decreased illicit opioid use among incarcerated individuals. At the same time, it addresses key challenges, such as logistical barriers, stigma, regulatory hurdles, and the need for staff training and secure medication protocols. By examining both the promise and the pitfalls, the presentation advocates for a more humane, evidence-based approach to addiction treatment behind bars.

Ann Jamieson, MS, LADC/MH, OKATOD President
Presenting "MOUD Advocacy in the Evolving Landscape of OTPs"
Learn more about Ms. JamiesonAnn Jamieson is the Chief Clinical Officer at Maric Healthcare, which operates 29 opioid treatment programs across seven states. Starting in 2000, Ms. Jamieson supported the expansion of OTPs by opening programs in North Carolina and Oklahoma. She also previously served as Chief Operating Officer at Maric. Ms. Jamieson obtained an MS in addiction and mental health counseling, earned a license as an addiction and mental health counselor and a license in clinical supervision, and provides a wealth of training to Maric Healthcare personnel through an online learning management system that she created and continues to use to educate staff members. She also serves as an administrative and program surveyor for the Commission for the Accreditation of Rehabilitation Facilities (CARF). Ms. Jamieson provided the leadership necessary to create the Oklahoma Association for the Treatment of Opioid Dependence (OKATOD) in 2010 and was elected its first president and AATOD board delegate. She also currently serves as AATOD’s second vice president. Ms. Jamieson continues to serve as OKATOD’s president today and holds annual OKATOD conferences, which serve to create partnerships and collaboration for treatment providers and other members of the community in Oklahoma.
Ms. Jamieson’s presentation will serve as an aid to providers and stakeholders in Oklahoma in understanding the current policy and regulatory climate, including the most recent legislative changes. Across the nation, there are efforts to increase access to opioid use disorder treatment to combat the opioid overdose crisis. AATOD has worked for decades on regulatory, legislative, and funding improvements to increase access to evidence-based treatment in safe and effective ways backed by science. In this session, participants will be informed of the current policy issues facing the treatment field and proposals for innovation and modernization in the context of growing calls for methadone and regulatory reform. The goal is to energize and activate additional advocates among conference participants and teach them to advocate for evidence-based policies to increase access to opioid treatment.
